We narrowed to 19,341 results for: gateway
-
Plasmid#60277PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertDNMT3A enhancer (DNMT3A Human)
UseGateway CloningAvailable sinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_37
Plasmid#60278PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertARHGAP26 enhancer (ARHGAP26 Human)
UseGateway CloningAvailable sinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_39
Plasmid#60280PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertPCSK1 enhancer (PCSK1 Human)
UseGateway CloningAvailable sinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C2_8
Plasmid#60249PurposeThis plasmid contains a human pancreatic islet inactive enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertRAP1A inactive enhancer (RAP1A Human)
UseGateway CloningAvailable sinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C2_10
Plasmid#60250PurposeThis plasmid contains a human pancreatic islet inactive enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertLINGO2 inactive enhancer (LINGO2 Human)
UseGateway CloningAvailable sinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C2_11
Plasmid#60251PurposeThis plasmid contains a human pancreatic islet inactive enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertSMYD3 inactive enhancer (SMYD3 Human)
UseGateway CloningAvailable sinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C2_13
Plasmid#60252PurposeThis plasmid contains a human pancreatic islet inactive enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertSPATA19 inactive enhancer (SPATA19 Human)
UseGateway CloningAvailable sinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C2_14
Plasmid#60253PurposeThis plasmid contains a human pancreatic islet inactive enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertEDARADD inactive enhancer (EDARADD Human)
UseGateway CloningAvailable sinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_5
Plasmid#60254PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertWSCD2 enhancer (WSCD2 Human)
UseGateway CloningAvailable sinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pDONR221_SLC29A2
Plasmid#132139PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC29A2 (SLC29A2 Human)
ExpressionMammalianAvailable sinceDec. 4, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR221_SLC38A5
Plasmid#132118PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC38A5 (SLC38A5 Human)
ExpressionMammalianAvailable sinceDec. 4, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR221_SLC27A3
Plasmid#132116PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC27A3 (SLC27A3 Human)
ExpressionMammalianAvailable sinceDec. 4, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR221_SLC35A2
Plasmid#132147PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC35A2 (SLC35A2 Human)
ExpressionMammalianAvailable sinceNov. 25, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR221_SLC9C1
Plasmid#132247PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC9C1 (SLC9C1 Human)
ExpressionMammalianAvailable sinceNov. 21, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR221_SLC26A9
Plasmid#132140PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC26A9 (SLC26A9 Human)
ExpressionMammalianAvailable sinceNov. 21, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR221_SLC38A4
Plasmid#132130PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC38A4 (SLC38A4 Human)
ExpressionMammalianAvailable sinceNov. 21, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR221_SLC4A3
Plasmid#132288PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC4A3 (SLC4A3 Human)
ExpressionMammalianAvailable sinceNov. 12, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR221_SPNS2
Plasmid#132307PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSPNS2 (SPNS2 Human)
ExpressionMammalianAvailable sinceNov. 8, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR221_SLC13A3
Plasmid#132309PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC13A3 (SLC13A3 Human)
ExpressionMammalianAvailable sinceNov. 8, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR221_SLC9B2
Plasmid#132235PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC9B2 (NHEDC2 Human)
ExpressionMammalianAvailable sinceNov. 8, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by